Comparative evaluation of the BD Phoenix and VITEK 2 automated instruments for identification of isolates of the Burkholderia cepacia complex

Journal of Clinical Microbiology

Volumn 40, Issue 5, 2002, Pages 1743-1748

  Brisse, Sylvain ^a   Stefani, Stefania ^a   Verhoef, Jan ^a   Van Belkum, Alex ^a   Vandamme, Peter ^a   Goessens, Wil ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ACCURACY; ACHROMOBACTER; ALCALIGENES FAECALIS; ARTICLE; AUTOMATION; BACTERIAL GENOME; BACTERIAL VIRULENCE; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATE; BURKHOLDERIA CEPACIA; COMPARATIVE STUDY; CONTROLLED STUDY; EPIDEMIC; HUMAN; INSTRUMENT; NONHUMAN; PRIORITY JOURNAL; RALSTONIA;

AUTOMATION; BURKHOLDERIA CEPACIA; BURKHOLDERIA INFECTIONS; HUMANS; REPRODUCIBILITY OF RESULTS; SEROTYPING;

ACHROMOBACTER; ACHROMOBACTER ALCALIGENES; ALCALIGENES FAECALIS; BACTERIA (MICROORGANISMS); BURKHOLDERIA; BURKHOLDERIA CEPACIA; BURKHOLDERIA MULTIVORANS; NEGIBACTERIA; PHOENIX; RALSTONIA; RALSTONIA PICKETTII; WAUTERSIA PAUCULA;

EID: 0036252196     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.40.5.1743-1748.2002     Document Type: Article

References (35)

1. Burkholderia cepacia genomovar III is a common plant-associated bacterium
2. Discrimination of Burkholderia gladioli from other Burkholderia species detectable in cystic fibrosis patients by PCR
3. Distinguishing species of the Burkholderia cepacia complex and Burkholderia gladioli by automated ribotyping
4. Sour skin, a bacterial rot of onion bulbs
5. Detection of Pseudomonas (Burkholderia) cepacia using PCR
6. Burkholderia cepacia genomovar VI, a new member of the Burkholderia cepacia complex isolated from cystic fibrosis patients
7. Burkholderia ambifaria sp. nov., a novel member of the Burkholderia cepacia complex including biocontrol and cystic fibrosis-related isolates
8. Identification of Burkholderia species and genomovars from cystic fibrosis patients by AFLP fingerprinting
9. Taxonomy and identification of the Burkholderia cepacia complex
10. Evaluation of the VITEK 2 system for rapid identification of medically relevant gram-negative rods
11. Pseudomonas and Burkholderia
12. 2-fixing isolates from rice in Vietnam
13. Burkholderia cepacia: Medical, taxonomic and ecological issues
14. Comparison of isolation media for recovery of Burkholderia cepacia complex from respiratory secretions of patients with cystic fibrosis
15. Identification of Burkholderia cepacia isolates from patients with cystic fibrosis and use of a simple new selective medium
16. Phenotypic methods for determining genomovar status of the Burkholderia cepacia complex
17. Agricultural use of Burkholderia (Pseudomonas) cepacia: A threat to human health?
18. Pseudomonas cepacia infection in cystic fibrosis: An emerging problem
19. Accuracy of four commercial systems for identification of Burkholderia cepacia and other gram-negative nonfermenting bacilli recovered from patients with cystic fibrosis
20. Burkholderia cepacia. Management issues and new insights
21. Development of rRNA-based PCR assays for identification of Burkholderia cepacia complex isolates recovered from cystic fibrosis patients
22. Disproportionate distribution of Burkholderia cepacia complex species and transmissibility markers in cystic fibrosis
23. DNA-based diagnostic approaches for identification of Burkholderia cepacia complex Burkholderia vietmamiensis, Burkholderia multivorans, Burkholderia stabilis, and Burkholderia cepacia genomovars I and III
24. Epidemiology of Burkholderia cepacia infection in patients with cystic fibrosis: Analysis by randomly amplified polymorphic DNA fingerprinting
25. Identification and characterization of a novel DNA marker associated with epidemic Burkholderia cepacia strains recovered from patients with cystic fibrosis
26. Misidentification of Burkholderia cepacia in U.S. cystic fibrosis treatment centers: An analysis of 1,051 recent sputum isolates
27. Evaluating biochemical identification systems
28. Differentiation of Burkholderia species by PCR-restriction fragment length polymorphism analysis of the 16S rRNA gene and application to cystic fibrosis isolates
29. Utility of commercial systems for identification of Burkholderia cepacia complex from cystic fibrosis sputum culture
30. Assignment of Centers for Disease Control group IVc-2 to the genus Ralstonia as Ralstonia paucula sp. nov
31. Occurrence of multiple genomovars of Burkholderia cepacia in cystic fibrosis patients and proposal of Burkholderia multivorans sp. nov
32. Identification and population structure of Burkholderia stabilis sp. nov. (formerly Burkholderia cepacia genomovar IV)
33. Identification of Burkholderia spp. in the clinical microbiology laboratory: Comparison of conventional and molecular methods
34. Selective and differential medium for recovery of Pseudomonas cepacia from the respiratory tracts of patients with cystic fibrosis
35. Comparison of culture and PCR for detection of Burkholderia cepacia in sputum samples of patients with cystic fibrosis